• 简体中文
  • English
登录 注册
当前位置: 首页 > FDA溶出度方法库 反馈纠错 帮助中心
-
药品名称 剂型 USP 溶出方法 转速(转/min) 溶出介质 容积 推荐采样时间 更新时间
Dexamethasone/Neomycin Sulfate/ Polymyxin B Sulfate Ophthalmic Suspension Develop a method to characterize in vitro release 2018-02-15
Ethinyl Estradiol/Norethindrone Acetate Tablet II (Paddle) 100 Phosphate Buffer, pH 6.8, containing 0.07% w/v Triton X 100 900 5, 10, 20, 30, 45, 60 and 75 2018-02-15
Mecamylamine HCl Tablet Refer to USP 2018-02-15
Metyrosine Capsule Refer to USP 2018-02-15
Nitisinone Tablet II (Paddle) 50 Phosphate Buffer, pH 6.8 2 mg tablets: 500 mL 10, 15, 20, 30, 45, 60, 75 and 90 2018-02-15
Methscopolamine Bromide Tablet Refer to USP 2018-02-15
Pregabalin Tablet (Extended Release) II (Paddle) 50 0.06 M HCl 900 1, 2, 4, 6, 8, 10, 12, 16 and 24 hours 2018-02-08
Medroxyprogesterone Acetate (104mg/0.65ml) Injectable Suspension Develop a method to characterize in vitro release 2018-02-08
Omeprazole (Orally Disintegrating) OTC Tablet (Delayed Release) II (Paddle) 100 Tablets are pre-exposed to 500 ml of 0.1M HCL for 2 hrs and then 400 ml of 0.235M Na2HP04 is added to the medium. Adjust if necessary with 2 N HCI or 2 N NaOH to a pH of 6.8 Acid stage: 500; Buf Acid stage: 120; Buffer stage: 10, 20, 30, 45 and 60 2018-02-08
Triamcinolone Acetonide Intra-Articular, For Suspension (Extended Release) II (Paddle) 75 0.3% SDS in 10 mM phosphate buffer, pH 7.2 + 0.02% sodium azide @35°C 1000 1, 2, 4, 8, 12, 16, 24, 36, 48, 72, 96 and 120 hours 2018-02-08
Aliskiren Hemifumarate Capsule (pellet) I (Basket) 100 0.01 M HCl (degas) 500 5, 10, 15, 20, 30 and 45 2018-02-08
Letermovir Tablet II (Paddle) 75 25 mM Na Acetate Buffer, pH 4.5 with 0.6% Tween-80 900 10, 15, 20, 30, 45 and 60 2018-02-08
Acalabrutinib Capsule II (Paddle) with sinker 50 0.1 M HCl 900 5, 10, 15, 20, 30 and 45 2018-02-08
Dolutegravir Na/Rilpivirine HCl Tablet II (Paddle) 75 1.0 % Tween 20 in 0.01 M HCl, pH 2.0 900 10, 15, 20, 30, 45 and 60 2018-02-08
Betrixaban Capsule II (Paddle) with sinker 75 0.01 N HCl, (with addition of pepsin if gelatin crosslinking is observed) 900 5, 10, 15, 20 and 30 2017-11-16
Delafloxacin Meglumine Tablet II (Paddle) 60 0.05 M Phosphate Buffer, pH 7.4 (degassed) 900 5, 10, 15, 20 and 30 2017-11-16
Naproxen Suspension Develop a dissolution method 2017-11-16
Abemaciclib Tablet II (Paddle) 75 0.01 N HCl 900 5, 10, 15, 20 and 30 2017-11-16
Bosentan Tablet (For Suspension) II (Paddle) 75 0.1 N HCl with 0.5% sodium dodecyl sulfate (SDS), pH 1.1 900 5, 10, 15, 20 and 30 2017-11-16
Methylphenidate Tablet (Extended Release, Orally Disintegrating ) II (Paddle) 75 Acid Stage: 0.1 N HCl; Buffer Stage: Phosphate Buffer, pH 6.8 Acid Stage: 900 mL; Acid Stage: 15, 30, 60, 120 minutes; Buffer Stage: 1, 2, 3, 4, 6 and 8 hours 2017-11-16